Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now

Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold

Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Ulcerative Colitis

Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.

Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

GB004 in Adult Subjects With Active Ulcerative Colitis